Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdul-Rahman Azizogli

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Advanced Therapeutics|January 15, 2024
Comparison of SGLT1, SGLT2, and Dual Inhibitor biological activity in treating Type 2 Diabetes MellitusAbdul-Rahman Azizogli, Michael R Vitti, Richa Mishra, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 14, 2022
How to Design PeptidesJoseph Dodd-O, Amanda M Acevedo-Jake, Abdul-Rahman Azizogli, et al.
Advanced Theory and Simulations|May 1, 2023
Rational Design of de novo CCL2 Binding PeptidesErika Davidoff Aguas, Abdul-Rahman Azizogli, Jatin Kashyap, et al.
ACS Omega|February 17, 2023
Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2Abdul-Rahman Azizogli, Varun Pai, Francesco Coppola, et al.
ACS Omega|September 2, 2024
Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"Abdul-Rahman Azizogli, Varun Pai, Francesco Coppola, et al.
Advanced Therapeutics|September 13, 2021
Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoVDisha Panchal, Jeena Kataria, Kamiya Patel, et al.
Nature Communications|February 19, 2024
Author Correction: Antiviral fibrils of self-assembled peptides with tunable compositionsJoseph Dodd-O, Abhishek Roy, Zain Siddiqui, et al.
Nature Communications|August 28, 2024
Author Correction: Antiviral fibrils of self-assembled peptides with tunable compositionsJoseph Dodd-O, Abhishek Roy, Zain Siddiqui, et al.
Nature Communications|February 7, 2024
Antiviral fibrils of self-assembled peptides with tunable compositionsJoseph Dodd-O, Abhishek Roy, Zain Siddiqui, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advanced Therapeutics|January 15, 2024
Comparison of SGLT1, SGLT2, and Dual Inhibitor biological activity in treating Type 2 Diabetes MellitusAbdul-Rahman Azizogli, Michael R Vitti, Richa Mishra, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 14, 2022
How to Design PeptidesJoseph Dodd-O, Amanda M Acevedo-Jake, Abdul-Rahman Azizogli, et al.
Advanced Theory and Simulations|May 1, 2023
Rational Design of de novo CCL2 Binding PeptidesErika Davidoff Aguas, Abdul-Rahman Azizogli, Jatin Kashyap, et al.
ACS Omega|February 17, 2023
Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2Abdul-Rahman Azizogli, Varun Pai, Francesco Coppola, et al.
ACS Omega|September 2, 2024
Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"Abdul-Rahman Azizogli, Varun Pai, Francesco Coppola, et al.
Advanced Therapeutics|September 13, 2021
Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoVDisha Panchal, Jeena Kataria, Kamiya Patel, et al.
Nature Communications|February 19, 2024
Author Correction: Antiviral fibrils of self-assembled peptides with tunable compositionsJoseph Dodd-O, Abhishek Roy, Zain Siddiqui, et al.
Nature Communications|August 28, 2024
Author Correction: Antiviral fibrils of self-assembled peptides with tunable compositionsJoseph Dodd-O, Abhishek Roy, Zain Siddiqui, et al.
Nature Communications|February 7, 2024
Antiviral fibrils of self-assembled peptides with tunable compositionsJoseph Dodd-O, Abhishek Roy, Zain Siddiqui, et al.
Pageof 1